The rate of students dropping out from UK universities has fallen slightly, figures show.
University of Oxford
The UK policy of leaving 12 weeks between doses of the Oxford/AstraZeneca coronavirus vaccine boosts the jab’s effectiveness, a new study has found.
Using dexamethasone to treat Covid-19 patients could have saved 650,000 lives around the world, a study suggests.
More than 1.7 million people have been asked to isolate via the NHS Covid-19 app since it launched in September, according to the Department of Health and Social Care (DHSC).
The University of Oxford accepted record numbers of British students from ethnic minority backgrounds last year.
Switzerland’s decision not to authorise use of the University of Oxford’s Covid-19 jab is between the country’s medical regulator and AstraZeneca, a leading vaccine expert has said.
The rate of healthcare workers testing positive for coronavirus dropped by 50% 12 days after they received the first Covid-19 vaccine dose, new data suggests.
Coronavirus cases, hospital admissions and deaths will continue to fall as the UK has passed the peak in the current wave of the pandemic, England’s chief medical officer has said.
Boris Johnson has warned that coronavirus infections remain “alarmingly high” and the NHS is still under “huge pressure”, despite promising vaccination data.
Vaccines against new coronavirus variants should be ready by October, the team behind the Oxford University/AstraZeneca jab has said.
The University of Oxford has released new data on its coronavirus vaccine which suggests the jab may reduce transmission by 67%.
Data from Oxford University showing its vaccine cuts transmission “will help us all to get out of this pandemic”, Matt Hancock has said, as hopes were raised over the lifting of lockdown.
A single dose of the Oxford vaccine may reduce transmission of coronavirus by two thirds, according to a new study which provides a major boost to the UK’s recommendation that the second jab should be delayed for up to 12 weeks.
The University of Oxford’s coronavirus vaccine offers protection of 76% up to 12 weeks after a single dose and may reduce transmission by 67%, according to a new study.
The world’s first single-shot Covid vaccine seems to offer some protection against the virus, but not as well as some two-shot rivals, trial results have shown.
Health officials are monitoring mutant coronavirus variants to see which ones could cause “vaccine evasion”, a senior Government adviser has said.
Indications the mutant coronavirus variant which emerged in the south of England may be more deadly and be more transmissible are a “serious turn for the worse”, a leading scientist has said.
New research suggests that since the first coronavirus lockdown, the number of people diagnosed with bowel cancer in England has fallen sharply, with a deficit persisting up to October 2020.
Private companies are increasingly being hired by governments and political parties to manipulate public opinion through social media, according to new research.
There is no limit to the benefits of exercise in reducing the risk of cardiovascular disease, according to a new study.
Targeting arterial stiffening earlier in a person’s life could provide benefits for brain health in older age – and may help to delay the onset of dementia, researchers suggest.
The first doses of the Covid-19 vaccine developed by the University of Oxford and AstraZeneca have been administered in the UK.
Every adult in Britain will be able to get a coronavirus vaccine, the Health Secretary has confirmed.
The Covid-19 vaccine developed by the University of Oxford and AstraZeneca has been approved for use in the UK.
The University of Oxford’s coronavirus vaccine induces an immune response and is safe, according to more data published by researchers.
The University of Oxford’s coronavirus vaccine stimulates broad antibody and T cell responses, published trial results show.
Russia’s coronavirus vaccine is up to 91.4% effective at stopping people developing Covid-19 symptoms, according to its developers.
The University of Oxford’s Covid-19 vaccine could be licenced for use in the elderly, the lead researcher of the trial has said.
As the NHS started rolling out the Pfizer/BioNTech vaccine, peer-reviewed results of phase three of the University of Oxford vaccine were published.
Oxford University’s Covid-19 vaccine “has a good safety record and efficacy” and could help control the pandemic, a scientist leading the study has said, as phase three data was published.